Altre lingue SUSMED,Inc.

Azioni

4263

JP3319150003

Mercato chiuso - Japan Exchange Altri mercati azionari 08:00:00 27/06/2024			Variaz. 5gg	Var. 1 gen.
600 ^JPY	+2,92%		+0,84%	-55,06%

2022	Walgreens Boots Alliance, Inc. si unisce al Partenariato per i Medicinali Sostenibili	CI
2022	Aculys Pharma e SUSMED stipulano un contratto per condurre la sperimentazione clinica utilizzando la tecnologia Blockchain.	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

SUSMED,Inc.(TSE:4263) added to S&P Global BMI Index	18/09/23
DTx von SUSMED wurde in Japan für die Behandlung von Schlaflosigkeit zugelassen	25/08/23
SUSMED’s DTx Approved in Japan for the Treatment of Insomnia	25/08/23
Walgreens Boots Alliance, Inc. Joins Sustainable Medicines Partnership	04/10/22
Aculys Pharma und SUSMED schließen Vertrag über Durchführung von weltweit erster klinischer Studie mit Blockchain-Technologie	14/07/22
Aculys Pharma and SUSMED Have Entered into a Contract to Conduct the World's First Clinical Trial Utilizing Blockchain Technology	13/07/22
Aculys Pharma and SUSMED Enter into A Contract to Conduct the Clinical Trial Utilizing Blockchain Technology	13/07/22
Certain Common Stock of SUSMED,Inc. are subject to a Lock-Up Agreement Ending on 21-JUN-2022.	21/06/22
Certain Common Stock of SUSMED,Inc. are subject to a Lock-Up Agreement Ending on 23-MAR-2022.	23/03/22
CollaboCreate Co., Ltd. announced that it has received funding from SUSMED,Inc.	10/03/22
Shionogi Signs up to $41 Million Commercialization Contract for Insomnia App	28/12/21
Shionogi & Co., Ltd. Announces Commercialization Agreement with SUSMED Co., Ltd. for Digital Therapeutic App for Insomnia	27/12/21
SUSMED,Inc. has completed an IPO in the amount of ¥3.65613 billion.	24/12/21
SUSMED,Inc. has filed an IPO.	19/11/21
SUSMED Co., Ltd. announced that it has received funding from Suzuken Co., Ltd.	30/10/20
SUSMED Co., Ltd. announced that it expects to receive funding from Suzuken Co., Ltd.	27/10/20
SUSMED Co., Ltd. announced that it has received ¥200 million in funding from Sumitomo Corporation	25/08/20
SUSMED Co., Ltd. announced that it expects to receive funding from Suzuken Co., Ltd.	11/05/20
SUSMED Co., Ltd. announced that it has received ¥720 million in funding from Tokyo Century Corporation, M3, Inc., SBI Investment Co., Ltd., Beyond Next Ventures Inc., Sony Innovation Fund, The Dai-Ichi Life Insurance Company, Limited	04/06/18

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Assicura e Aumenta la Performance dei tuoi Investimenti con il nostro Team di Esperti al tuo fianco

Assicurare i miei Investimenti

fermer